Daniel Boxwell, DO
Facial Plastic Surgery · Seneca, SCNPI 1518181148
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $4,418 of the $7,226 with a category attached, or 61.1%. 21 manufacturers reported payments, led by Stryker at 57.9% of the total. 2025 is the largest year on record at $4,484, more than ten times the $75 reported in 2019.
Across 96 payments — averaging $75.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$4K
- Aerin Medical Inc.$2K
- GSK$312
- Regeneron Healthcare Solutions, Inc.$156
- Phathom Pharmaceuticals, Inc.$140
- Acclarent, Inc$130
- plus $585 from 15 others
What the payments were for
- Travel & lodging$4,41861%
- Food & beverage$2,80839%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 19 | $4,185 |
| Aerin Medical Inc. | 17 | $1,718 |
| GSK | 22 | $312 |
| Regeneron Healthcare Solutions, Inc. | 5 | $156 |
| Phathom Pharmaceuticals, Inc. | 2 | $140 |
| Acclarent, Inc | 6 | $130 |
| Neurent Medical Limited | 6 | $123 |
| Actelion Pharmaceuticals US, Inc. | 2 | $70 |
| Boehringer Ingelheim | 3 | $66 |
| Sanofi | 2 | $62 |
| Intersect ENT, Inc. | 2 | $39 |
| AstraZeneca | 1 | $35 |
| Advanced Bionics, LLC | 1 | $26 |
| Lundbeck LLC | 1 | $25 |
| Amgen | 1 | $23 |
| ANI Pharmaceuticals, Inc. | 1 | $21 |
| Insmed, Inc. | 1 | $21 |
| Xoran Technologies LLC | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| United Therapeutics Corporation | 1 | $19 |
| Pfizer | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SCOPIS ENT$3,299
- VIVAER STYLUS$1,208
- XPRESS LOPROFILE$303
- SHAVER SYSTEM$168
- LATERA$168
- CLARIFIX$168
- FIAGON NAVIGATION UNIT$126
- VOQUEZNA$123
How this compares
Too few facial plastic surgery providers in South Carolinato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 174 | $4,776 |
| Epinephrine | 23 | $3,898 |
| Famotidine | 217 | $3,005 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 11 | $1,455 |
| Pantoprazole Sodium | 108 | $1,225 |
| Fluocinolone Acetonide Oil | 24 | $999 |
| Fluticasone Propionate | 85 | $865 |
| Mupirocin | 140 | $760 |
| Omeprazole | 72 | $706 |
| Amitriptyline Hcl | 60 | $696 |
| Ofloxacin | 36 | $682 |
| Prednisone | 42 | $418 |
| Doxycycline Hyclate | 14 | $365 |
| Clotrimazole | 15 | $357 |
| Topiramate | 18 | $334 |
Paid to pharmacies, not to this prescriber.
Other facial plastic surgery in Seneca
- Drew CollinsSeneca$43
- William WellsLexington$659K
- David RodwellCharleston$49K
- Krishna PatelCharleston$6K
- John RichColumbia$4K
- Sam MeshkinfamFlorence$3K
- Daniel GerryFort Mill$2K
- Peter BondyConway$1K
- Judith SkonerCharleston$988
- Patrick AngelosCharleston$615
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.